Mckesson (MCK) Total Non-Current Liabilities (2009 - 2026)
Mckesson (MCK) reported Total Non-Current Liabilities of -$2.4 billion for Q1 2026, up 9.19% year-over-year from -$2.2 billion in Q1 2025, and down 102.87% quarter-over-quarter from $82.7 billion in Q4 2025.
Mckesson (MCK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 17 years of Total Non-Current Liabilities data on file, last reported at -$2.4 billion in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at -$2.4 billion, up 9.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 billion (up 9.19% YoY), and the FY2026 annual result was -$2.4 billion, up 9.19% from the prior year.
- Total Non-Current Liabilities eased to -$2.4 billion in Q1 2026 per MCK's latest filing, from $82.7 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $82.8 billion in Q3 2025 and troughed at -$2.6 billion in Q1 2025.
- A 5-year average of $51.8 billion and a median of $64.3 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities plunged 45.97% in 2024, then rose 16.25% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $63.0 billion in 2022, then grew by 4.51% to $65.8 billion in 2023, then rose by 8.16% to $71.2 billion in 2024, then climbed by 16.25% to $82.7 billion in 2025, then slumped by 102.87% to -$2.4 billion in 2026.
- Business Quant data shows MCK's Total Non-Current Liabilities at -$2.4 billion in Q1 2026, $82.7 billion in Q4 2025, and $82.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.72 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.37 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 329.13 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 6.05 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.79 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 58.52 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 279.68 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 40.66 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.37 Bn |
| Dec 31, 2025 | 82.75 Bn |
| Sep 30, 2025 | 82.76 Bn |
| Jun 30, 2025 | 78.06 Bn |
| Mar 31, 2025 | -2.61 Bn |
| Dec 31, 2024 | 71.18 Bn |
| Sep 30, 2024 | 72.36 Bn |
| Jun 30, 2024 | 68.77 Bn |
| Mar 31, 2024 | -2.57 Bn |
| Dec 31, 2023 | 65.81 Bn |
| Sep 30, 2023 | 65.36 Bn |
| Jun 30, 2023 | 63.26 Bn |
| Mar 31, 2023 | -1.76 Bn |
| Dec 31, 2022 | 62.98 Bn |
| Sep 30, 2022 | 62.79 Bn |
| Jun 30, 2022 | 62.21 Bn |
| Dec 31, 2021 | 62.88 Bn |
| Sep 30, 2021 | 62.12 Bn |
| Jun 30, 2021 | 61.19 Bn |
| Dec 31, 2020 | 60.28 Bn |